Thumbnail Image
Publication

Futibatinib: second EMA approval for FGFR inhibitor in cholangiocarcinoma

Lamarca, Angela
; 
Vogel, A
Citations
Altmetric:
Abstract
Authors
Lamarca, Angela
Vogel, A
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Description
Date
2023
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Found with Open Access Button
Adobe PDF, 646.67 KB
Keywords
Type
Other
Citation
Lamarca A, Vogel A. Futibatinib: second EMA approval for FGFR inhibitor in cholangiocarcinoma. ESMO open. 2023 Nov 1;8(6):102049. PubMed PMID: 37922686. Epub 2023/11/06. eng.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/626716
Embedded videos